Certified by Founder Lodge
Maxion Therapeutics
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2023 | Series A | $16,000,000 | |
| March, 18 ,2025 | Series A | $72,000,000.00 | |
| March, 18 ,2025 | Series A | $72,000,000.00 |
BGF
LifeArc Ventures
Monograph Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Elly | $8,000,000 | (Feb 26, 2026)
Quill Meetings | $6,500,000 | (Feb 26, 2026)
Abram Scientific | $11,750,000 | (Feb 26, 2026)
Cicada | $13,500,000 | (Feb 26, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)